ClinicalTrials.govpublic full text
Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients
cytomegalovirus (cmv), transplant, treatment, resistant, cmv, refractory, cytomegalovirus, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 807528
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.